Long COVID endotheliopathy: hypothesized mechanisms and potential therapeutic approaches
J Ahamed, J Laurence - The Journal of clinical investigation, 2022 - Am Soc Clin Investig
SARS-CoV-2–infected individuals may suffer a multi–organ system disorder known as “long
COVID” or post-acute sequelae of SARS-CoV-2 infection (PASC). There are no standard …
COVID” or post-acute sequelae of SARS-CoV-2 infection (PASC). There are no standard …
The long-term health outcomes, pathophysiological mechanisms and multidisciplinary management of long COVID
J Li, Y Zhou, J Ma, Q Zhang, J Shao, S Liang… - … and Targeted Therapy, 2023 - nature.com
There have been hundreds of millions of cases of coronavirus disease 2019 (COVID-19),
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With …
which is caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). With …
The epidemiology of diabetic kidney disease
EK Hoogeveen - Kidney and Dialysis, 2022 - mdpi.com
Globally, the incidence and prevalence of diabetes mellitus has risen dramatically, owing
mainly to the increase in type 2 diabetes mellitus (T2DM). In 2021, 537 million people …
mainly to the increase in type 2 diabetes mellitus (T2DM). In 2021, 537 million people …
Thromboinflammation in long COVID—the elusive key to postinfection sequelae?
Long COVID is a public health emergency affecting millions of people worldwide,
characterized by heterogeneous symptoms across multiple organ systems. Here, we discuss …
characterized by heterogeneous symptoms across multiple organ systems. Here, we discuss …
Multiorgan MRI findings after hospitalisation with COVID-19 in the UK (C-MORE): a prospective, multicentre, observational cohort study
B Raman, C McCracken, MP Cassar… - The Lancet …, 2023 - thelancet.com
Introduction The multiorgan impact of moderate to severe coronavirus infections in the post-
acute phase is still poorly understood. We aimed to evaluate the excess burden of …
acute phase is still poorly understood. We aimed to evaluate the excess burden of …
Balancing the value and risk of exercise-based therapy post-COVID-19: a narrative review
Coronavirus disease 2019 (COVID-19) can lead to ongoing symptoms such as
breathlessness, fatigue and muscle pain, which can have a substantial impact on an …
breathlessness, fatigue and muscle pain, which can have a substantial impact on an …
Current and future strategies for targeting the endothelin pathway in cardiovascular disease
GR Abraham, TL Williams, JJ Maguire… - Nature Cardiovascular …, 2023 - nature.com
Abstract The first endothelin (ET)-1 receptor antagonist was approved for clinical use over
20 years ago, but to date this class of compounds has been limited to treating pulmonary …
20 years ago, but to date this class of compounds has been limited to treating pulmonary …
Cardiac manifestations of post-acute COVID-19 infection
KO Mohammad, A Lin, JBC Rodriguez - Current cardiology reports, 2022 - Springer
Abstract Purpose of Review There is emerging evidence that the post-acute and chronic
phases of COVID-19 infection are associated with various significant cardiovascular …
phases of COVID-19 infection are associated with various significant cardiovascular …
Mitochondrial dysfunction and coenzyme Q10 supplementation in post-viral fatigue syndrome: an overview
D Mantle, IP Hargreaves, JC Domingo… - International Journal of …, 2024 - mdpi.com
Post-viral fatigue syndrome (PVFS) encompasses a wide range of complex neuroimmune
disorders of unknown causes characterised by disabling post-exertional fatigue, myalgia …
disorders of unknown causes characterised by disabling post-exertional fatigue, myalgia …
Microfluidic-based technologies for diagnosis, prevention, and treatment of COVID-19: recent advances and future directions
The COVID-19 pandemic has posed significant challenges to existing healthcare systems
around the world. The urgent need for the development of diagnostic and therapeutic …
around the world. The urgent need for the development of diagnostic and therapeutic …